VolitionRX

VNRX · NYSE American

$0.1732−$0.0006 (−0.35%)TodayMarket closed ·
Prev close $0.1738

About VNRX

VolitionRX Ltd. engages in the development of blood-based cancer tests to help diagnose a range of cancers. The company is headquartered in Henderson, Nevada and currently employs 75 full-time employees. The company went IPO on 2015-02-06. The firm is dedicated to saving lives and improving outcomes for people and animals with life-altering diseases through earlier detection, as well as disease and treatment monitoring. Through its subsidiaries, it is developing and commercializing blood tests to help diagnose and monitor a range of diseases, including cancers and diseases associated with NETosis, such as sepsis. Its key pillars are Nu.Q Vet, Nu.Q NETs, Nu.Q Discover, Nu.Q Cancer, and Capture-PCR. The Nu.Q Vet Cancer Test is commercially available as a cancer screening test in dogs. Nu.Q NETs is monitoring the immune system to save lives. Nu.Q Discover is a complete solution to profiling nucleosomes. Nu.Q Cancer monitoring disease progression, response to treatment and minimal residual disease. Capture-PCRTM is isolating and capturing circulating tumor-derived DNA from plasma samples for early cancer detection.

Employees
75
Headquarters
Henderson, Nevada
Listed
Feb 6, 2015
Sector
Health Care
Industry
Health Care Equipment & Supplies

Leadership

VolitionRX executives
NameTitleSince
Timothy Still——
Cameron Reynolds—2011
Terig Hughes——
Salvatore Butera—2020
Jasmine Kway——
Gaetan Michel——
Louise Batchelor——
Jacob Micallef——
Nicholas Plummer——
Gael Forterre——
Andrew Retter——
Rodney Rootsaert——
Phillip Barnes——
Alan Colman——
Mickie Henshall——
Guy Innes——
Kim Nguyen——
Ethel Rubin——

Suppliers and customers

Price correlation is over one year: 1 means the stocks move together, -1 opposite

VolitionRX suppliers and customers
CompanyRelationshipCorrelation
Texas A&M UniversitySupplier and customer—
Active Motif, Inc.Supplier and customer—
German Cancer Research CenterSupplier and customer—
National Taiwan UniversitySupplier and customer—

Similar companies

Companies in the same industry as VolitionRX

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.